Duration of antifungal treatment in mold infection: when is enough?

Vera Portillo1, Dionysios Neofytos

  • 1Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland.

PubMed
Abstract

Insights

Defining the optimal duration for antifungal treatment of invasive mold infections (IMI) is challenging due to poorly understood resolution criteria. Evidence is needed to guide decisions on stopping treatment in immunocompromised patients.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Invasive mold infections (IMI) are serious complications in immunocompromised individuals.
  • Current guidelines lack precise definitions for treatment cessation, relying on clinical/radiological resolution and immune recovery.
  • Existing data suggest prolonged treatment durations, often blurring the line with secondary prophylaxis.

Approach:

  • Review of current guidelines and available real-life data on IMI treatment duration.
  • Analysis of the challenges in defining treatment response and immune reconstitution.
  • Identification of the need for evidence-based algorithms for treatment de-escalation.

Key Points:

  • Optimal duration for antifungal therapy in IMI remains undefined.
  • Definitions for clinical/radiological resolution and immune recovery are scarce.
  • Distinguishing prolonged treatment from secondary prophylaxis requires clear definitions.

Conclusions:

  • Decisions to stop antifungal treatment for IMI are based on limited evidence and expert opinion.
  • More research is essential to establish optimal treatment durations.
  • Development of practical algorithms is crucial for guiding clinicians in IMI management.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
41
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
41
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
43
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
200